Dextrose Injection Market to Surpass US$ 14,056.6 Million by 2027 - Coherent Market Insights

Global Dextrose Injection Market, By Product Type (5% Dextrose Injection, 10% Dextrose Injection, 50% Dextrose Injection, 70% Dextrose Injection, and Others), By Application (First-aid Treatment, Sports, Trophotherapy, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Increasing research and development activities for the development of novel application of dextrose injection is expected to drive the market growth over the forecast period.

For instance, according to the article published in the journal of American Academy of Physical Medicine and Rehabilitation in October 2019, therapeutic injection of dextrose is applicable in prolotherapy, perineural injection therapy, and hydrodissection. Prolotherapy includes injection of hypertonic dextrose to treat chronic musculoskeletal pain.

Perineural injection treatment (PIT) with dextrose include the injection of dextrose adjacent to peripheral nerves to reduce neuropathic pain. In that procedure isotonic dextrose solution (5% dextrose in water; D5W) is most commonly used. Furthermore, hydrodissection with dextrose is injected adjacent to peripheral nerves with continuous ultrasound guidance to release peripheral nerves from their encasing fascia in order to provide a decompressive effect.

Global Dextrose Injection Market – Impact of Coronavirus (Covid-19) Pandemic

The COVID-19 pandemic has impacted the global economy and in turn, the dextrose injection market. Quarantine, traveling constraints, and social distancing measures are likely to lead to a steep decline in business and consumer spending until the end of the second quarter of 2020. Moreover, dextrose injection solution is used in hospitalized patients for nutrition support, to treat low blood sugar, and to decrease high potassium levels in the blood. Due to increasing patient population suffering from COVID-19 and increasing hospital admission of patients are expected to increase demand for dextrose injection as a supplemental therapy for patient recovery.

Browse 36 Market Data Tables and 35 Figures spread through 180 Pages and in-depth TOC on “Dextrose Injection Market”- Global Forecast to 2027, By Product Type (5% Dextrose Injection, 10% Dextrose Injection, 50% Dextrose Injection, 70% Dextrose Injection, and Others), By Application (First-aid Treatment, Sports, Trophotherapy, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),

To know the latest trends and insights prevalent in the global dextrose injection market, click the link below:

https://www.coherentmarketinsights.com/market-insight/dextrose-injection-market-1835

Furthermore, robust clinical trial pipeline of drugs is expected to drive the market growth over the forecast period. For instance, in February 2017, Tri service general hospital, a medical center in Neihu District, Taipei, Taiwa, completed its 5% Dextrose injection phase 1 clinical trials. 5% dextrose injection is used to treat ulnar neuropathy (peripheral entrapment neuropathy) at elbow. Since 2017, Tri service general hospital reported to have 10% dextrose injection in phase 2 clinical trials. 10% dextrose injection is used to treat Carpal tunnel syndrome. Carpal tunnel syndrome causes pain, numbness, and tingling in the hands. It occurs when the media nerve is squeezed or compressed, as it travels through the wrist.

Key Takeaways of the Global Dextrose Injection Market:

• The global dextrose injection market is expected to expand at a CAGR of 5.7% during the forecast period, owing to increasing approval of novel drugs. For instance, in February 2016, Aurobindo Pharmaceuticals Ltd. received the U.S. FDA approval for Levofloxacin Injection in dextrose injection, which is indicated for treatment of bacterial infection in adults.
• Among product type, 5% dextrose injection segment is estimated to hold a dominant position in the global dextrose injection market in 2020, owing to its less side effects on body as compared to other dextrose injections and it is mostly used to treat low blood sugar (hypoglycemia), insulin shock or dehydration (fluid loss).
• Among application, first-aid treatment segment is estimated to hold a dominant position in the global dextrose injection market in 2020 due to its application in first-aid treatment as a nutrition support
• Key players operating in the global dextrose injection market include Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.